[ET Net News Agency, 19 August 2026] Morgan Stanley raised the target price for Innovent Bio (01801) to HKD138.5 from HKD135 and maintained the "overweight" rating.
The research house said it raises FY26-28 product revenue/total revenue by 6%/5%/2%, respectively. (rc)
The research house said it raises FY26-28 product revenue/total revenue by 6%/5%/2%, respectively. (rc)